Search results for "Irritable bowel syndrome"
Treatments for irritable bowel syndrome examined
A network meta-analysis looked at trials comparing soluble fiber, antispasmodic drugs, peppermint oil, and gut-brain neuromodulators with each other or with placebo, while a randomized controlled trial tested fecal microbiota transplantation.
https://gastroenterology.acponline.org/archives/2019/12/27/1.htm
27 Dec 2019
Spotlight on irritable bowel syndrome
In the past month, researchers assessed potential treatments of irritable bowel syndrome (IBS), reviewed likely causes of the condition, and quantified the daily challenges facing patients with IBS.
https://gastroenterology.acponline.org/archives/2019/08/23/5.htm
23 Aug 2019
In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months
While fecal microbiota transplantation was effective in patients with moderate to severe irritable bowel syndrome in a randomized trial, long-term risks of the therapy remain uncertain, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2020/05/22/10.htm
22 May 2020
New Annals Virtual Patients series features case on irritable bowel syndrome
Annals Virtual Patients is an interactive medical education program that uses virtual patient simulation to test physicians' decision-making skills.
https://gastroenterology.acponline.org/archives/2018/09/28/8.htm
28 Sep 2018
Spotlight on irritable bowel syndrome
Irritable bowel syndrome (IBS) was the focus of two recent studies this month, which analyzed patients with symptoms of diarrhea-predominant IBS and IBS after infectious enteritis.
https://gastroenterology.acponline.org/archives/2017/01/27/6.htm
27 Jan 2017
Acute gastroenteritis infection associated with later IBS, functional dyspepsia, review finds
Prevalence of irritable bowel disease and functional dyspepsia were 14.5% and 12.7%, respectively, in patients who had experienced acute gastroenteritis, a risk more than three times higher than that in uninfected patients.
https://gastroenterology.acponline.org/archives/2024/07/26/1.htm
26 Jul 2024
In the Clinic, 2023 summary highlight gastroenterology topics
Colorectal cancer screening was the focus of the latest In the Clinic article, while an article in a supplement to Annals reviewed clinically important developments in gastroenterology and hepatology in 2023.
https://gastroenterology.acponline.org/archives/2024/04/26/5.htm
26 Apr 2024
In primary care, second-line IBS therapy with amitriptyline vs. placebo reduced symptoms at 6 mo
An ACP Journal Club commentary said the high-quality randomized trial provides pragmatic guidance on amitriptyline dosing in patients with irritable bowel syndrome (IBS), as well as additional support for the drug as an option in primary care after first-line therapies fail.
https://gastroenterology.acponline.org/archives/2024/02/23/7.htm
23 Feb 2024
Low-dose amitriptyline appears effective as second-line treatment for IBS
Patients with irritable bowel syndrome (IBS) who were randomized to titrated doses of a tricyclic antidepressant had significant improvements in their IBS symptom scores at six months compared to those receiving a placebo, a trial in primary care found.
https://gastroenterology.acponline.org/archives/2023/10/27/2.htm
27 Oct 2023
More tools available for treating IBS
Irritable bowel syndrome (IBS) is not a new disorder, but understanding of its pathophysiology and treatment has greatly progressed over the years.
https://gastroenterology.acponline.org/archives/2023/02/24/7.htm
24 Feb 2023